首页|期刊导航|河南中医|柴胡加龙骨牡蛎汤加味治疗慢性萎缩性胃炎临床研究

柴胡加龙骨牡蛎汤加味治疗慢性萎缩性胃炎临床研究OA

Clinical Study on Supplemented Bupleurum Decoction Plus Dragon Bones and Oyster Shell in the Treatment of Chronic Atrophic Gastritis

中文摘要英文摘要

目的:观察柴胡加龙骨牡蛎汤加味治疗慢性萎缩性胃炎的临床疗效.方法:将120 例慢性萎缩性胃炎患者按照随机数字表法分为研究组和对照组,每组各60 例.对照组口服奥美拉唑肠溶胶囊及胶体果胶铋胶囊,研究组在对照组治疗的基础上联合柴胡加龙骨牡蛎汤加味治疗.比较两组患者的临床疗效及治疗前后中医证候积分、血清胃功能指标[胃泌素 17(gastrin 17 antigen,G-17)、胃蛋白酶原Ⅰ(pepsinogen Ⅰ,PG Ⅰ)、胃蛋白酶原Ⅱ(pepsinogen Ⅱ,PG Ⅱ)、内皮素-1(endothelin-1,ET-1)]、炎症因子水平[肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、白细胞介素-6(interleukin-6,IL-6)和C反应蛋白(C-reactiveprotein,CRP)]和胃黏膜组织病理评分.结果:两组患者治疗后胃脘灼热、胃脘痞闷、纳呆食少、神疲乏力、口苦口臭及总分均低于本组治疗前,且治疗后研究组低于对照组,差异均有统计学意义(P<0.05).研究组有效率为91.67%,对照组有效率为78.33%,两组患者有效率比较,差异具有统计学意义(P<0.05).研究组治疗后G-17、PG Ⅰ和PGⅡ水平分别为(385.43±31.02)ng·L-1、(122.15±12.09)ng·L-1和(25.62±3.26)ng·L-1,高于本组治疗前及对照组治疗后,差异具有统计学意义(P<0.05),研究组治疗后ET-1、CRP、IL-6 和TNF-α水平为(65.52±7.53)ng·L-1,低于本组治疗前及对照组治疗后,差异具有统计学意义(P<0.05).两组患者治疗后各项胃黏膜组织病理评分均低于本组治疗前及对照组治疗后,差异具有统计学意义(P<0.05).结论:柴胡加龙骨牡蛎汤加味治疗慢性萎缩性胃炎,可有效改善患者的临床症状、胃功能指标、炎症反应及胃黏膜病理状态.

Objective:To observe the clinical efficacy of Supplemented Bupleurum Decoction Plus Dragon Bones and Oyster Shell on chronic atrophic gastritis(CAG).Methods:A total of 120 CAG patients were divided into the study group and the control group using the random number table method,with 60 cases in each group.The control group received Omeprazole Enteric-coated Capsules and Col-loidal Bismuth Pectin Capsules for oral administration.The study group received Supplemented Bupleurum Decoction Plus Dragon Bones and Oyster Shell in addition to the treatment given to the control group.The clinical efficacy,and changes in TCM syndrome scores,ser-um gastric function indicators[including Gastrin-17(G-17),Pepsinogen Ⅰ(PG Ⅰ),Pepsinogen Ⅱ(PG Ⅱ),Endothelin-1(ET-1)],levels of inflammatory factors[including tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),and C-reactive protein(CRP)],and histopathological scores of gastric mucosa before and after treatment were compared between the two groups.Results:After treatment,scores for epigastric burning,epigastric fullness and stuffiness,poor appetite,fatigue and lassitude,bitter taste and halitosis,as well as the total scores,were lower than those before treatment within each group.Furthermore,these scores were lower in the study group than in the control group,with all differences being statistically significant(P<0.05).The effective rate was91.67%in the study group and 78.33%in the control group,showing a statistically significant difference(P<0.05).After treatment,the levels of G-17,PG Ⅰ,and PG Ⅱ in the study group were(385.43±31.02)ng·L-1,(122.15±12.09)ng·L-1,and(25.62±3.26)ng·L-1,respectively,which were higher than those before treatment in the same group and higher than those in the control group after treat-ment(P<0.05).The levels of ET-1,CRP,IL-6,and TNF-αin the study group after treatment were(65.52±7.53)ng·L-1,which were lower than those before treatment in the same group and lower than those in the control group after treatment(P<0.05).All path-ological scores of gastric mucosal tissues in the two groups after treatment were lower than those before treatment within each group,and the scores in the study group were lower than those in the control group(P<0.05).Conclusion:Supplemented Bupleurum Decoction Plus Dragon Bones and Oyster Shell is effective in treating CAG,which can significantly improve clinical symptoms,gastric function in-dicators,inflammatory response,and the pathological state of gastric mucosa of the patients.

YUAN Shuaiqiang;HOU Liufa;WANG Fei;ZHAO Lei;LOU Jing

Henan Integrative Medicine Hospital,Zhengzhou,Henan,China,450004Henan Integrative Medicine Hospital,Zhengzhou,Henan,China,450004Henan Integrative Medicine Hospital,Zhengzhou,Henan,China,450004Henan Integrative Medicine Hospital,Zhengzhou,Henan,China,450004Henan Integrative Medicine Hospital,Zhengzhou,Henan,China,450004

医药卫生

慢性萎缩性胃炎柴胡加龙骨牡蛎汤加味奥美拉唑肠溶胶囊胶体果胶铋胶囊中西医结合疗法《伤寒论》张仲景

《河南中医》 2026 (1)

35-40,6

河南省中医药传承与创新人才工程(仲景工程)中医药学科领军人才项目{豫中医函[2021]8号}河南省中医药传承与创新人才工程(仲景工程)中医药拔尖人才第二批培养项目{豫卫中医函[2021]15号}

10.16367/j.issn.1003-5028.2026.01.0006

评论